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Angiotensin influences on tubuloglomerular feedback mechanism in
hypertensive rats. The tubuloglomerular feedback (TGF) mechanism
was evaluated in the nonclipped kidney of Goldblatt hypertensive rats
from both stop flow pressure (SFP) and single nephron glomerular
filtration rate (SNGFR) responses to step increases in late proximal
perfusion rate from 0 to 40 nI/mm. During control conditions, increases
in late proximal perfusion rate produced flow dependent decreases in
SFP and SNGFR with maximal values of 10.2 1.0mm Hg and 12.9
2.5 nI/mm, values similar to those obtained in normal rats. During ACE
inhibition (MK 422; 0.6 mg/kg/hr), arterial pressure decreased from 168
8 to 137 7 mm Hg and there was a marked attenuation in the
magnitude of SFP feedback responses ( = 2.5 0.3 mm Hg). SNGFR
feedback responses, however, were not significantly impaired. Direct
decreases in renal arterial pressure reduced control SFP but SFP
feedback responses were maintained, indicating that the attenuated
SFP feedback responses during ACE inhibition were not due to
decreased arterial pressure. Superimposed infusion of angiotensin II
during ACE inhibition partially restored SFP feedback responses. In
contrast, norepinephrine infusion did not result in a similar restoration
of SFP feedback sensitivity. These results indicate that the nonclipped
kidney of Goldblatt hypertensive rats has an intact TGF mechanism as
assessed from SFP and SNGFR feedback responses. Furthermore,
ACE inhibition attenuates SFP but not SNGFR feedback responses,
and systemic angiotensin II infusions can restore SFP feedback respon-
siveness towards normal.
Experiments in the 2-kidney, 1-clip Goldblatt hypertensive
rat model have suggested that angiotensin II exerts a profound
influence on renal function of the nonclipped contralateral
kidney, thereby rendering this kidney unable to respond to the
increased blood pressure with adequate natriuresis and diuresis
[1—31. It has been shown that blockade of angiotensin II
receptors by competitive antagonists or inhibition of angioten-
sin II generation by angiotensin converting enzyme (ACE)
inhibitors results in renal vasodilation, increased glomerular
filtration rate (GFR) and increased sodium excretion of the
nonclipped kidney in spite of substantial decreases in arterial
pressure [1—7]. Results from micropuncture studies have dem-
onstrated that, when given during the early stages of renal
hypertension, ACE inhibitors elevate single nephron GFR and
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reduce proximal tubular fluid reabsorption in the nonclipped
kidney [6, 71.
In an earlier study it was reported that tubuloglomerular
feedback (TGF) responses are attenuated in the nonclipped
kidney [8]. Because renin levels are markedly depressed in the
nonclipped kidney [1, 81 it was suggested that a reduction in
intrarenal angiotensin II activity was responsible for the impair-
ment of feedback responses. Subsequently it was shown that
renal tissue angiotensin II levels in the nonclipped kidney are
not suppressed [9]. In addition, Muller-Suur et a! [10] failed to
observe impaired stop flow pressure (SFP) feedback responses
in the nonclipped kidney. Because of the importance of the
TGF mechanism in maintaining a balance between filtered
volume and tubular reabsorptive processes [11, 12], and in view
of the evidence that angiotensin II can modulate feedback
sensitivity [13—14], we were prompted to evaluate in greater
detail the TGF mechanism in the nonclipped kidney of
Goldblatt hypertensive rats and the influence of angiotensin II
on this mechanism. Accordingly, an ACE inhibitor (MK 422)
was used to block angiotensin II formation [16] and TGF
responses were determined during infusion of the ACE inhibi-
tor. Because ACE inhibition led to reductions in arterial pres-
sure as well as attenuation of SFP feedback responses, we
evaluated SFP feedback responses after mechanical reduction
of arterial pressure. We also assessed the ability of systemic
angiotensin II infusions to restore feedback responsiveness. To
determine if the effects of angiotensin II were simply a conse-
quence of vasoconstriction and restoration of arterial pressure,
similar experiments were performed during norepinephrine
infusions.
Methods
Two-kidney, one-clip Goldblatt hypertensive rats were pre-
pared as described previously [1] by constricting the right renal
artery with a silver clip having an internal gap of 0.25 mm. The
clipping procedure was performed four weeks prior to the
experiment on 100 to 150 g male Sprague-Dawley rats anesthe-
tized with sodium pentobarbital (40 mg/kg, i.p.). Sham-operated
rats served as controls. All rats were maintained on a commer-
cial diet (Wayne Lab. Blox, Chicago, Illinois, USA) containing
0.15 mEq/g sodium and were allowed tap water ad libitum.
Experiments were performed on rats weighing between 240 and
360 g. In preparation for the micropuncture measurements, rats
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were anesthetized with sodium pentobarbital (50 mg/kg, i.p.)
and placed on a servo-controlled heated table. Rectal temper-
ature was maintained at 37°C. The trachea was cannulated with
a polyethylene tube to maintain a patent airway. Catheters were
inserted into the right external jugular vein for infusion of
isotonic saline solution (0.02 mI/mm) and for administration of
drugs and supplemental anesthetic as needed. The left femoral
artery was cannulated with a polyethylene catheter (PE-50) to
collect blood samples and measure blood pressure. Arterial
blood pressure was continuously monitored using a Statham
P23DC transducer (Gould-Statham Instruments Inc., Hato Rey,
Puerto Rico) and a P7 Grass polygraph (Grass Instrument Co.,
Quincy, Massachusetts, USA).
The left kidney was isolated through a transverse subcostal
incision and placed in a Lucite holder. The kidney was immo-
bilized with warmed agar which was molded to form a well on
the surface of the kidney. The ureter was catheterized with
PE-lO tubing for timed urine collections. After completion of
surgery, 0.3 ml of 15% mutest solution (polyfructosan in 154
mM NaC1, Laevosan-Gesellschaft, Linz, Austria) was adminis-
tered as a prime dose and followed by an infusion at 0.01
ml/min. The total fluid inlusion rate was kept unchanged
throughout the experiment by reducing the rate of isotonic
saline infusion to 0.01 mI/mm. One hour was allowed for
equilibration before initiating micropuncture procedures.
The kidney surface was illuminated with a fiber optic light
source connected to a quartz rod. A proximal tubule segment
was randomly selected and punctured with a 1 to 2 m
micropipette filled with artificial tubular fluid (ATF) stained
with 0.1% fast green dye. The artificial tubular fluid contained:
Na, 145 mEq/liter; C1, 135 mEq/liter; K, 5 mEq/liter;
HC03, 10 mEq/Iiter; Ca, 4 mEq/liter; 2 mEq/liter;
PO4, 2 mEq/liter; S04, 2 mEq/liter; urea, 250 mg/liter. A
proximal convoluted tubule with three or more surface seg-
ments was identified and selected for nephron microperfusion.
As previously described [17], the intermediate segment of the
proximal tubule was blocked with wax using a micropipette
filled with bone wax and driven by a hydraulic microdrive
(Trent Wells, South Gate, California, USA). A I to 2 m
pressure micropipette was placed in the earliest segment of the
proximal tubule and the stop flow pressure (SFP) was measured
with a servo-null micropressure measuring system (Instrumen-
tation for Physiology and Medicine, San Diego, California,
USA). After a stable control SFP was obtained, a 8 m
perfusion micropipette filled with tinted ATF and connected to
a variable speed microperfusion pump (Walter Klotz, Munich,
FRG) was inserted into the last proximal tubule segment distal
to the wax block. Perfusion was initiated at 10 nl/min and
randomly increased between 10 and 40 nI/mm with step-gra-
dients of 5 or 10 nI/mm, The perfusion rate was then returned
back toO nI/mm. Each perfusion rate was maintained for at least
two minutes to allow SFP to reach a stable value and was
repeated twice. SFP responses to the same perfusion rate were
averaged. In addition, the free flow hydrostatic pressures of the
proximal tubule, the distal tubule and the peritubular capillaries
were measured as described previously [6, 7]. A timed urine
sample was collected under oil during each experimental peri-
od. Arterial blood samples of 100 d each were taken at the
beginning and the end of each experimental period. The sepa-
rated plasma was pooled for analysis.
To assess SNGFR feedback responses, an identification
pipette containing stained ATF was inserted into a randomly
selected surface proximal tubule and a small amount of solution
was injected to identify early and late segments of the proximal
tubule. A wax block was inserted into an intermediate proximal
segment and a perfusion pipette containing stained ATF was
placed into a terminal proximal tubule segment. After the
control collections from the earlier segment of the proximal
tubule, perfusion was initiated at 15 nI/mm and maintained for
two to three minutes after the stained perfusate appeared in the
distal segments. A proximal tubular fluid sample was collected
at this perfusion rate and the perfusion rate was increased
further to 35 nI/mm and an additional fluid collection was
obtained. The perfusion was then terminated and an additional
proximal tubular fluid collection was made.
TGF feedback experiments were conducted on five groups of
rats. The first group consisted of sham-operated normotensive
rats and the other four groups consisted of hypertensive rats. In
groups 1 to 3, SFP feedback responses and free-flow tubular
and capillary pressures were obtained during the control period.
Then, MK 422 (Enalaprilat, Merck Sharp & Dohme, Rathway,
New Jersey, USA) was administered intravenously as a priming
dose of 0.2 mg/kg followed by an infusion at 0.6 mg/kg/hr. To
test the effectiveness of MK 422, the systemic blood pressure
increase to intravenous administration of 15 or 25 ng angioten-
sin I was assessed before and during infusion of MK 422. After
a 30 minute equilibration period, the micropuncture measure-
ments were repeated. Subsequently, either angiotensin II [6 to
12 ng/kg/min, groups 1 (N 7) and 2 (N =6)1 or norepinephrine
[100 to 400 g/kg/mmn, group 3 (N = 4)] was administered while
the MK 422 infusion was continued. The doses were initially
selected to restore arterial pressure back to control values.
These were generally reached with the angiotensin II infusions;
however, the norepinephrine infusions sometimes had to be
reduced because higher doses led to blanching of the kidney
surface. SFP feedback responses to changes in late proximal
perfusion rate and superficial cortical pressure measurements
were repeated. In the fourth group of rats (N = 5), an adjustable
clamp was placed around the aorta between the renal arteries.
SFP feedback responses were measured at spontaneous pres-
sure and at reduced renal perfusion pressure. In the fifth group
of rats (N = 5), SNGFR feedback responses were determined
during the control period and during infusion of MK 422. In a
sixth group of clipped rats (N = 5), renal blood flow (RBF)
responses were assessed by placing an electromagnetic flow
transducer (Carolina Medical Electronics, Inc., King, North
Carolina, USA) on the left renal artery [18]. Measurements of
RBF were obtained during control conditions, following admin-
istration of MK 422, and during superimposed angiotensin II or
norepinephrine infusions.
At the end of each experiment, the left kidney was excised,
blotted dry and weighed. Urine volumes were determined
gravimetrically. Plasma and urine polyfructosan, sodium and
potassium concentrations were measured as described previ-
ously [11. The volume of the proximal tubular fluid samples was
measured with a slide comparator (Gaertner Scientific Corp.,
Chicago, Illinois, USA). Tubular fluid polyfructosan concentra-
tions were measured using a fluorometric technique [19].
Plasma colloid osmotic pressure was measured using a Wescor
4100 colloid osmometer (Wescor Inc., Logan, Utah, USA).
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was not statistically significant. Likewise, urine flow and so-
dium excretion were not significantly altered from the levels
obtained with MK 422 alone. In normotensive rats, MK 422
infusion alone or with subsequent addition of angiotensin II did
not alter GFR, urine flow, or sodium excretion significantly.
The cortical nephron hydrostatic pressure response to MK
422 and MK 422 plus angiotensin II in normal and hypertensive
rats are shown in Figure 1. SFP during the control period was
higher in hypertensive rats than in normal rats (44.1 1.3 vs.
39.7 1.4 mm Hg, P < 0.05). Since arterial plasma colloid
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osmotic pressures were similar (13.4 0.6 mm Hg for hyper-
tensive rats vs. 13.0 0.5 mm Hg for normal rats), estimated
glomerular pressure based on the sum of SFP and plasma
C ACEI ACEI + All C ACE ACE - All colloid osmotic pressure was higher in hypertensive rats than in
Hypertensive N 10 Normotensive N = 7 normal rats (57.6 1.6 vs. 53.0 1.4 mm Hg, P < 0.05). These
Fig. 1. Effects of angiotensin converting enzyme inhibition (A GEl) and
ACE! plus angiotensin II (All) on mean arterial blood pressure
data are in accord with results based on direct glomerular
pressure measurements in Munich-Wistar rats [22, 23]. The
(MABP), estimated glomerular pressure (GP), preglomerular pressure
drop (MABP-GP), proximal tubular pressure (PTP), distal tubularhPS pentUbtrCapdf,reSsU,e
to the preceding period,
free-flow proximal and distal intratubular pressures and the
peritubular capillary hydrostatic pressure of hypertensive rats
were similar to those of normal rats. Administration of MK 422
did not change the estimated glomerular pressure of hyperten-
sive rats (57.7 1.8 mm Hg) but decreased it in normal rats
(48.6 0.8 mm Hg). Since arterial pressure decreased substan-
GFR and SNGFR were calculated by the standard formulas. tially in the absence of concomitant changes in estimated
Data are presented as mean standard error. Differences glomerular pressure in the hypertensive rats, the preglomerular
between the control and experimental observations within pressure gradient (MABP-GP) decreased significantly in re-
groups were analyzed by paired Student's i-test, and those sponse to ACE inhibition in hypertensive rats. This decrease in
between groups were analyzed using ANOVA followed by the preglomerular pressure drop was greater in hypertensive
Duncan's multiple range test. rats (from 110 7 to 79 5 mm Hg) than in normal rats (from
Results
71 2.7 to 56 3.1 mm Hg). In both groups there were no
significant changes in free flow intratubular pressure and pen-
The effectiveness of inhibition of angiotensin I converting tubular capillary pressure following MK 422. Addition of suffi-
enzyme by MK 422 was tested in three normal rats and five cient angiotensin II during continued MK 422 infusion to
hypertensive rats before and during MK 422 infusion. Before restore arterial pressure to control values (from 137 7 to 176
MK 422 administration, intravenous injection of 15 and 25 ng 3 mm Hg) resulted in a return of the preglomerular pressure
angiotensin I increased mean arterial blood pressure by 29 7 drop in both groups of rats towards the normal. Estimated
and 37 9 mm Hg in normal rats and by 44 8 and 58 8 mm glomerular pressure was not changed significantly (57.6 1.6 to
Hg in hypertensive rats. During MK 422 infusion, the same 57.7 1.8 mm Hg) in the hypertensive rats during combined
doses of angiotensin I increased mean arterial blood pressure by drug infusion. In normal rats, proximal and distal tubular
1 0.7 and 7 2 mm Hg in normal rats (96 4% and 80 5% pressures decreased significantly during combined drug infu-
inhibition) and 3 2 and 8 3 mm Hg in hypertensive rats (94 sion compared to MK 422 infusion alone, but were not signifi-
4% and 87± 4% inhibition). cantly different from the values obtained during the initial
As previously reported for other ACE inhibitors [1—7, 20—22], control period.
systemic administration of MK 422 reduced arterial blood The SFP feedback responses to increases in late proximal
pressure from 168 8 to 137 7 mm Hg (P < 0.001) in perfusion rate in normal rats were similar to those observed
hypertensive rats and from 124 3 to 106 3 mm Hg (P < previously [13, 15, 17, 20, 21, 241 and are summarized in Table
0.001) in normal rats (Fig. 1). Despite the fall in arterial 1. The maximal decrease in SFP obtained at 40 nl/min perfusion
pressure, the contralateral kidneys of the hypertensive rats rate averaged 11.1 1.3 mm Hg (28.8 3.9%). Termination of
exhibited significant increases in GFR (1.36 0.16 to 1.75 perfusion restored the SFP to near control levels. During MK
0.24 mi/mm, P < 0.05), urine flow (4.1 0.3 to 6.1 0.8 422 infusion, SFP responses to increases in late proximal
pi/min), sodium excretion rate (0.19 0.07 to 0.53 0.18 perfusion rate were markedly attenuated. Maximal decreases in
tEq/min, P <0.05), potassium excretion rate (0.88 0.15 to SFP averaged only 2.7 0.6 mm Hg or 7.6 1.9% (P < 0.01).
1.63 0.24 pEq/min, P < 0.001) and fractional excretion rates As shown previously [13], during co-administration of angio-
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Table 1. Effects of MK 422 and MK 422 + angiotensin II (All) on SFP feedback responses in normal rats
Period 0
Perfusion rate ni/mm
10 15 20 30 40 Recovery
Control (17/7)
MK 422 (13/7)
MK 422 + All
(9/5)
39.7 1.4
35.4 0.6
39.3 2.7
37.3 1.6
34.1 0.9
37.0 2.6
31.9 2.7
33.9 0.9
34.8 3.2
29.4 2.3
34.0 1.1
33.4 3.2
29.4 2.4
33.3 1.1
32.1 2.6
29.4 2.4
32.8 1.0
32.2 2.3
39.3 1.5
34.8 0.9
39,1 1.9
Numbers in parentheses indicate number of tubules/number of rats studied.
tensin II with an ACE inhibitor the SFP responses to distal
perfusion were partially restored. At the highest perfusion rate,
the average decrease in SFP was 7.7 0.9 mm Hg (20.0
3.0%).
The SFP and SNGFR feedback responses in hypertensive
rats are shown in Figure 2. Before administration of MK 422,
each rat exhibited decreases in either SFP or SNGFR in
response to increases in late proximal perfusion rate. Maximal
SFP feedback responses averaged 10.2 1.0 mm Hg (24.2
2.7%). Administration of MK 422 substantially attenuated SFP
feedback responses with maximal reductions in SFP at the
highest perfusion rate averaging only 2.5 0.3 mm Hg (6.1
Fig. 3. Paired comparisons of stop flow pressure (SFP) feedback
responses in hypertensive rats during control conditions (left panels),
during combined infusion of MK 422 and angiotensin II (upper right
panel) and during combined infusion of MK 422 and norepinephrine
(lower right panel). The responses obtained during MK 422 alone are
shown in Fig. 2.
0.8%). Interestingly, the SNGFR feedback responses were not
significantly altered by MK 422 infusion. The maximal SNGFR
feedback responses during MK 422 infusion averaged 13.7
3.6 ni/mm (39.0 5.2%),which was not significantly different
from that observed during the pre-infusion period (12.9 2.5
ni/mm or 41.2 5.5%).
Because the SNGFR feedback responses were not signifi-
cantly attenuated by ACE inhibition, only SFP feedback re-
sponses were tested in the additional studies. As shown in
Figure 3, the reduced feedback responsiveness seen during MK
422 infusion alone was partially restored when angiotensin II
infusions were superimposed. Average maximal SFP feedback
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Fig. 2. Stop flow pressure (SFP) and single nephron glomerularfiltra-
tion rate (SNGFR) feedback responses in hypertensive rats during
control conditions (left panel) and during infusion of MK422 (right
panel).
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responses returned to 8.1 1.9mm Hg (15.4 3.9%). Infusion
of norepinephrine returned blood pressure from 125 7 mm Hg
during MK 422 administration to 140 7 mm Hg but failed to
restore the SFP feedback responsiveness (maximal 1.5 0.3
mm Hg). The failure to restore feedback sensitivity was appar-
ently not due to the inability of norepinephrine to elicit vaso-
constriction. Indeed, in group 6 rats, RBF decreased by a
greater amount during norepinephrine infusions than during
angiotensin II infusions. As shown in Figure 4, angiotensin II
caused RBF to decrease by 28 6% in association with an
increase in arterial pressure from 126 8 mm Hg to 159 5 mm
Hg. In contrast, RBF decreased by 64 5% with norepineph-
rine infusions that raised arterial pressure to 145 16 mm Hg.
In terms of the relative responsiveness of the renal vascular
bed, there was a 1.44 0.46% decrease in RBF per percent
increase in arterial pressure during angiotensin II infusion,
while this index was significantly greater (3.2 1.0%) during
norepinephrine infusions.
To evaluate if the effects of ACE inhibition on the SFP
feedback responses were due primarily to decreases in arterial
pressure, renal perfusion pressure was reduced from 170 11
to 132 6 mm Hg by suprarenal aortic clamping in a separate
group of rats (N = 5). In this group, mechanical reduction in
systemic arterial pressure was associated with a significant
reduction in SFP from 47.9 1.0mm Hg to 37.0 0.8 mm Hg.
As previously shown in normal rats [24] reductions in arterial
pressure did not significantly attenuate the absolute magnitude
of the feedback response (Fig. 5). The magnitude of the
maximal SFP feedback response to a late proximal perfusion
rate of 40 nl/min was 12.0 1.8mm Hg (25.3 4.2%) during the
control period and 11.4 3.0 mm Hg (31.2 8.6%) during
reduced pressure.
Discussion
Earlier studies from several laboratories have demonstrated
that activation of the renin-angiotensin system due to constric-
tion of one renal artery is largely responsible for the initiation
Fig. 4. Renal blood flow (RBF) responses of
the nonclipped kidney of hypertensive rats to
infusion of MK422 (left panel), MK422 plus
angiotensin II (center panel) and MK422 plus
norepinephrine (right panel). * P < 0.05; ** P
<0.01 as compared to the preceding period.
and perhaps the maintenance of hypertension in this model
[1—7, 22—23]. In addition to systemic vascular effects of the
elevated angiotensin II, there appear to be significant renal
effects which prevent the nonclipped kidney from responding
appropriately to the elevation in blood pressure. Although the
nonclipped kidney is renin depleted [1, 3, 8—10], the intrarenal
angiotensin II levels may not be suppressed [91. Thus, the
continued existence of local as well as circulating angiotensin II
levels may exert substantial influences on the nonclipped kid-
ney as well as on the clipped kidney. Administration of ACE
inhibitors have been shown to increase glomerular filtration rate
and the excretory function of the nonclipped kidney [1, 6,7]. In
the present experiments we utilized another converting enzyme
inhibitor, MK 422, which also led to decreases in arterial
E
0
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C
*
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I I
MK422 All
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BP = 170 11 mmHg
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Fig. 5. Stop flow pressure (SFP) feedback responses in hypertensive
rats during control conditions (left panel) and during reductions in renal
perfusion pressure (right panel).
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pressure and increases in RBF, GFR, urine flow and sodium
excretion in the nonclipped kidney. These results are in general
agreement with the previous studies in rats and dogs [1—7, 13,
23] and support further the contention that the nonclipped
kidney is under a pronounced influence of angiotensin II.
The effects of angiotensin II on glomerular function may be
mediated by several mechanisms, including a direct effect on
glomerular contractile elements and arterioles [25, 26]. In the
present study, changes in estimated glomerular capillary pres-
sure in the absence of orthograde perfusion to the distal
nephron were used to provide an indirect index of preglomer-
ular resistance. As noted before [231, glomerular capillary
pressure was significantly greater in the nonclipped kidney of
the hypertensive rats than in normal kidneys. Because of the
higher arterial pressures, however, the pressure gradient calcu-
lated from systemic arterial pressure and estimated glomerular
capillary pressure was higher in the hypertensive rats. These
data are consistent with findings that preglomerular resistance
is markedly elevated in the nonclipped kidney of the Goldblatt
hypertensive rat [3, 22, 23, 27]. Following MK 422, glomerular
pressure of hypertensive rats was not significantly diminished
from control levels despite a profound reduction in the arterial
pressure associated with an increased RBF. The quantitative
extent to which maintenance of glomerular pressure following
MK 422 was due to a direct effect of ACE inhibition or to an
autoregulatory response to the decrease in arterial pressure can
not be ascertained from these data. Autoregulatory capability of
the nonclipped kidney may exhibit variable degrees of impair-
ment [3, 18, 281, and it is possible that these rats did not have a
significant impairment of RBF autoregulatory capability as
previously reported [8]. In the present study, when renal
arterial pressure was reduced mechanically, there was a sub-
stantial decrease in estimated glomerular pressure which was
not seen following MK 422 administration. These differences
suggest a pre-glomerular vasodilatory effect of ACE inhibition
not due simply to the associated reduction in arterial pressure.
The TGF responsiveness of the nonclipped kidney of hyper-
tensive rats has been reported to be either unchanged [10] or
diminished [8]. In these rats, increases in late proximal per-
fusion rate during control conditions resulted in significant
decreases in both SEP and SNGFR. The reason for the discrep-
ancies among studies may be due to the duration of hyperten-
sion, the size of the constricting clip placed on the opposite
kidney and other intrarenal factors. In the present experiments,
we used a slightly larger clip (0.25 mm) than used in other
studies [8, 18]. This clip usually does not induce a malignant
phase and provides a relatively stable level of hypertension in
the range of 160 to 180 mm Hg. The attenuated TGF responses
obtained in a previous study [81 could possibly be due to the use
of a smaller clip which may have induced a malignant phase of
hypertension and led to accelerated vascular disease. The
present observations suggest that normal TGF responsiveness
is maintained by the nonclipped kidney during the early phases
of Goldblatt hypertension. It remains to be determined if there
is actually an augmentation of the TGF mechanism of the
nonclipped kidneys during the initiation phase of hypertension,
as has been reported for two different strains of spontaneously
hypertensive rats [29, 30].
The precise role for angiotensin II in the TGF response in
either normal or hypertensive states remains incompletely
understood. A role for angiotensin II in the TGF mechanism is
suggested by the 40 to 50% inhibition of SFP feedback re-
sponses obtained in normal rats with converting enzyme inhib-
itors or angiotensin antagonists [13, 20, 21, 31, 32]. As con-
firmed in the present study, ACE inhibition with MK 422 was
also very effective in blunting the magnitude of feedback
mediated reductions in SFP. The maximal SFP feedback re-
sponses were inhibited by 76% in normal rats and by 74 to 79%
in hypertensive rats. Recent studies in normal rats have shown
that angiotensin II infused systemically or directly into the
postglomerular circulation to increase interstitial angiotensin II
above endogenous levels can enhance feedback sensitivity [14,
151. Also, in normal rats with reduced TOE sensitivity due to
ACE inhibition, angiotensin II infusions were able to restore
partially the SFP feedback responses [13, 21]. In accord with
observations from normal rats, we demonstrated that systemic
angiotensin II infusion to hypertensive rats given MK 422 led to
partial restoration of SEP feedback sensitivity. Collectively,
these results indicate that angiotensin II serves as an important
modulator of SEP feedback sensitivity [13—15, 261. Interesting-
ly, the infusion of norepinephrine during continued MK 422
infusion failed to restore SEP feedback responsiveness in a
manner similar to that achieved with angiotensin II. This failure
to restore feedback responsiveness was not due to an insensi-
tivity of the renal vascular bed to norepinephrine. As previously
noted, raising of the BP to control levels with norepinephrine
infusion was sometimes precluded by blanching of the cortical
surface of the kidney. In the group six animals in which RBE
responses were measured, infusions of angiotensin II and
norepinephrine which raised blood pressure to similar levels
resulted in a much larger fall in RBF after norepinephrine
infusion than after angiotensin II infusion. These results suggest
that angiotensin II uniquely modulates SFP feedback activity
and does not act simply as a nonspecific vasoconstrictor. It is
also unlikely that the diminished SEP feedback responsiveness
during MK 422 administration was due to the associated fall of
arterial blood pressure, since a similar reduction in renal
perfusion pressure by mechanical clamping of the suprarenal
aorta did not induce a significant reduction in SEP feedback
responsiveness. These results are consistent with previous
studies in normal animals demonstrating that lowering of arte-
rial pressure does not attenuate the magnitude of SEP feedback
responses [24, 33]. In the study by Selen and Persson [241, SEP
feedback responses were actually enhanced during prolonged
reductions in renal perfusion pressure.
In contrast to the impressive decreases in the magnitude of
SEP feedback responses in normal and hypertensive rats at all
perfusion rates tested, MK 422 did not perceptibly attenuate the
SNGFR feedback responses to increases in late proximal tubule
perfusion rate in the nonclipped kidney of hypertensive rats.
This result is similar to that reported by Persson, Gushwa and
Blantz [321 in normal Munich-Wistar rats treated with both an
ACE inhibitor and a cyclooxygenase inhibitor. The reason for
the different responses in the SEP and SNGFR feedback
responses remains unclear. It has been suggested that the
maintenance of an intact SNGER feedback response under
conditions where glomerular pressure responsiveness is absent
may be due to activation of a mechanism which decreases
nephron plasma flow by parallel effects on the glomerular
contractile elements, thus raising pre- and postglomerular re-
Huang ci a!: Angiotensin effects on TGF in hypertension 637
sistance jointly [32, 34]. This latent mechanism is apparently
more likely under conditions of reduced efferent arteriole
resistance which allows a greater reserve for possible feedback
induced vasoconstriction. Such a mechanism, however, is
apparently not expressed when glomerular pressure feedback
responsiveness is intact since the decreases in glomerular
capillary pressure seem to be quite sufficient to account for the
reductions in SNGFR [11, 12, 35]. Further studies evaluating
the glomerular pressure and SNGFR responses in the same
preparation during changes in distal volume delivery before and
during ACE inhibition will be necessary to establish the quantita-
tive contributions of different mechanisms to the feedback medi-
ated changes in SNGFR in both normal and hypertensive rats.
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